SD

Sumitra Devi

Active Director Director DIN 09836613
DIN 09836613 First appointment Dec 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2022
Shareholding value •••• Premium profile

About Sumitra Devi

Data last updated:

Sumitra Devi is a Director at Hexa Medical Private Limited (since 2022). The company operates in Healthcare. Hexa Medical Private Limited reported revenue of ₹1.88 Cr (FY 2025).

DIN 09836613
Primary Designation Director
Industry Healthcare
First Appointment 27 Dec 2022
Oldest Company Age 5 yrs
Largest company Hexa Medical Private Limited · ₹1.88 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hexa Medical Private Limited U51909KA2021PTC146617
Director27 Dec 20222021₹1.88 Cr (FY 2025)Active

Board colleagues of Sumitra Devi

NameDINCompanyDesignation
Garvit Agarwal09148949Hexa Medical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Hexa Medical Private Limited
Premium access

Shareholding and investment profile for Sumitra Devi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sumitra Devi

Sumitra Devi currently holds 1 directorship: Hexa Medical Private Limited (Director, since 27 Dec 2022, revenue ₹1.88 Cr (FY 2025)).

Sumitra Devi was first appointed on 27 Dec 2022 as Director at Hexa Medical Private Limited.

The current boards of Sumitra Devi's companies include Garvit Agarwal (Hexa Medical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available